US 9,522,188 B2
Abuse resistant transmucosal drug delivery device
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 9,522,188 B2
Abuse resistant transmucosal drug delivery device
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Michael G Hartley
Art Unit:
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
Inventors:
Andrew Finn; Niraj Vasisht
Priority:
12/13/05
Filed:
12/13/06
Granted:
12/20/16
Expiration:
04/24/34
Abstract
The present invention relates to a solid pharmaceutical dosage form for abusable drug delivery with reduced illicit abuse potential. The dosage form is presented as a bioerodable transmucosal delivery device that includes an abusable drug and an antagonist to the abusable drug associated with an abuse-resistant matrix. The devices of the invention may be in the form of a layered film or a tablet. Upon application in a non-abusive manner, the device adheres to the mucosal surface, providing transmucosal drug delivery of the drug with minimal absorption of the antagonist into systemic circulation.
Cooperative Patent Classification (CPC)
A61A61K2300/00A61P25/30A61K

Analytics

Cases

Patent Assignments

Citations